Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 24,992 | 25,678 | 22,119 | 25,694 | 20,696 |
| Operating Income | -24,992 | -25,678 | -22,119 | -25,694 | -20,696 |
| Other Income | 2,048 | 1,733 | 1,272 | 865 | 409 |
| Pre-tax Income | -22,944 | -23,945 | -20,847 | -24,829 | -20,287 |
| Net Income Continuous | -22,944 | -23,945 | -20,847 | -24,829 | -20,287 |
| Net Income | $-22,944 | $-23,945 | $-20,847 | $-24,829 | $-20,287 |
| EPS Basic Total Ops | -0.50 | -0.53 | -0.52 | -0.63 | -0.51 |
| EPS Basic Continuous Ops | -0.50 | -0.53 | -0.52 | -0.63 | -0.51 |
| EPS Diluted Total Ops | -0.50 | -0.53 | -0.52 | -0.63 | -0.51 |
| EPS Diluted Continuous Ops | -0.50 | -0.53 | -0.52 | -0.63 | -0.51 |
| EBITDA(a) | $-25,996 | $-26,286 | $-22,492 | $-25,843 | $-20,543 |